Show news: from last 30 days (default), 60 days, 90 days, last visit or all

FDA approves naloxone nasal spray

26th November 2015

The US Food and Drug Administration (FDA) has approved a naloxone nasal spray (Narcan; Adapt Pharma) to treat opioid overdose. The US Product Information can be downloaded from here. It is expected to be commercially available in the US early 2016.

click here to view